Progresión en glaucoma. Guía de práctica clínica
- Laia Jaumandreu 14
- Alfonso Antón 234
- Marta Pazos 45
- Ignacio Rodriguez-Una 46
- Iñaki Rodriguez Agirretxe 47
- José María Martínez-De-La-Casa 49
- Miriam Eleonora Ayala 24
- M. Parrilla-Vallejo 48
- Agnieszka Anna Dyrda 2
- Laura Díez-Álvarez 14
- Gema Rebolleda 14
- Francisco José Muñoz-Negrete 14
-
1
Hospital Ramón y Cajal
info
- 2 Institut Català de la Retina (ICR), Barcelona, España
-
3
Universitat Internacional de Catalunya
info
-
4
Instituto de Salud Carlos III
info
-
5
Hospital Clinic Barcelona
info
-
6
Universidad de Oviedo
info
-
7
Hospital Universitario de Donostia
info
-
8
Hospital Universitario Virgen Macarena
info
-
9
Hospital Clínico San Carlos de Madrid
info
ISSN: 0365-6691
Año de publicación: 2023
Volumen: 98
Número: 1
Páginas: 40-57
Tipo: Artículo
Otras publicaciones en: Archivos de la Sociedad Española de Oftalmologia
Resumen
Objective To provide general recommendations that serve as a guide for the evaluation and management of glaucomatous progression in daily clinical practice based on the existing quality of clinical evidence. Methods After defining the objectives and scope of the guide, the working group was formed and structured clinical questions were formulated following the PICO (Patient, Intervention, Comparison, Outcomes) format. Once all the existing clinical evidence had been independently evaluated with the AMSTAR 2 (Assessment of Multiple Systematic Reviews) and Cochrane «Risk of bias» tools by at least two reviewers, recommendations were formulated following the Scottish Intercollegiate Guideline network (SIGN) methodology. Results Recommendations with their corresponding levels of evidence that may be useful in the interpretation and decision-making related to the different methods for the detection of glaucomatous progression are presented. Conclusions Despite the fact that for many of the questions the level of scientific evidence available is not very high, this clinical practice guideline offers an updated review of the different existing aspects related to the evaluation and management of glaucomatous progression.